| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 38, 813-816, Copyright © 1992 by American Association for Clinical Chemistry
BG van Engelen, KJ Lamers, FJ Gabreels, RA Wevers, WJ van Geel and GF Borm
Department of Neurology, University Hospital Nijmegen, The Netherlands.
Studies on cerebrospinal fluid (CSF) concentrations of neuron-specific enolase (NSE), S-100 protein, and myelin basic protein (MBP) in patients with neurological lesions indicate a quantitative relation between the degree of cell damage in the central nervous system (CNS) and the concentration of these CNS-specific proteins in CSF. Thus NSE, S-100, and MBP could be of use as markers for destructive processes in the CNS. We collected 937 specimens of CSF from children and adults (from newborns to age 91 years) who were undergoing a diagnostic lumbar puncture for several clinical indications. Of these, 79 samples from subjects ranging in age from 0.7 to 66 years could be used retrospectively to construct a reference interval according to our criteria. In these 79 samples no sex dependency existed. The relative increase of NSE, S-100, and MBP with age was similar (1% per year), suggesting a common underlying mechanism. These results emphasize the necessity of using age-matched reference values when the CNS-specific proteins are to be evaluated in neurological diseases. We also present three case histories to discuss the possible clinical relevance of the measurement of NSE, S-100, and MBP in children and adults.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  J Steiner, H Bielau, H-G Bernstein, B Bogerts, and M T Wunderlich Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1284 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Ben Abdesselam, J. Vally, C. Adem, M.-J. Foglietti, and J.-L. Beaudeux Reference Values for Serum S-100B Protein Depend on the Race of Individuals Clin. Chem., May 1, 2003; 49(5): 836 - 837. [Full Text] [PDF]
|
|
|
|
|
|
F. Michetti and D. Gazzolo S100B Protein in Biological Fluids: A Tool for Perinatal Medicine Clin. Chem., December 1, 2002; 48(12): 2097 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V.C. Portela, A. B.L. Tort, D. V. Schaf, L. Ribeiro, D. B. Nora, R. Walz, L. N. Rotta, C. T. Silva, J. V. Busnello, F. Kapczinski, et al. The Serum S100B Concentration Is Age Dependent Clin. Chem., June 1, 2002; 48(6): 950 - 952. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wong, K. Ess, and M. Landt Cerebrospinal Fluid Neuron-Specific Enolase Following Seizures in Children: Role of Etiology J Child Neurol, April 1, 2002; 17(4): 261 - 264. [Abstract] [PDF]
|
|
|
|
|
|
J de Vries, W A M H Thijssen, S E A Snels, T Menovsky, N G M Peer, and K J B Lamers Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 671 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sjogren, H. Vanderstichele, H. Agren, O. Zachrisson, M. Edsbagge, C. Wikkelso, I. Skoog, A. Wallin, L.-O. Wahlund, J. Marcusson, et al. Tau and A{beta}42 in Cerebrospinal Fluid from Healthy Adults 21-93 Years of Age: Establishment of Reference Values Clin. Chem., October 1, 2001; 47(10): 1776 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Masetti and N. T. Kouchoukos S-100{beta} protein: Yet uncertain role as a marker of cerebral injury in cardiac surgery J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 830 - 831. [Full Text]
|
|
|
|
|
|
M. Ohta, K. Ohta, J. Ma, J. Takeuchi, T. Saida, M. Nishimura, and N. Itoh Clinical and Analytical Evaluation of an Enzyme Immunoassay for Myelin Basic Protein in Cerebrospinal Fluid Clin. Chem., September 1, 2000; 46(9): 1326 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahashi, A. Chamczuk, Y. Hong, and G. Jackowski Rapid and Sensitive Immunoassay for the Measurement of Serum S100B Using Isoform-specific Monoclonal Antibody Clin. Chem., August 1, 1999; 45(8): 1307 - 1311. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sellebjerg, M. Christiansen, P. M. Nielsen, and J. L Frederiksen Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis Multiple Sclerosis, December 1, 1998; 4(6): 475 - 479. [Abstract] [PDF]
|
|
|
|
|
|
L. Lindberg, A-K. Olsson, K. Anderson, and P. Jogi SERUM S-100 PROTEIN LEVELS AFTER PEDIATRIC CARDIAC OPERATIONS: A POSSIBLE NEW MARKER FOR POSTPERFUSION CEREBRAL INJURY J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 281 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Grocott, N. D. Croughwell, D. W. Amory, W. D. White, J. L. Kirchner, and M. F. Newman Cerebral Emboli and Serum S100{beta} During Cardiac Operations Ann. Thorac. Surg., June 1, 1998; 65(6): 1645 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wiesmann, U. Missler, D. Gottmann, and S. Gehring Plasma S-100b Protein Concentration in Healthy Adults Is Age- and Sex-Independent Clin. Chem., May 1, 1998; 44(5): 1056 - 1058. [Full Text] [PDF]
|
|
|
|
|
|
P. J H Jongen, K. J B Lamers, W. H Doesburg, W. A J G Lemmens, and O. R Hommes Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis J. Neurol. Neurosurg. Psychiatry, October 1, 1997; 63(4): 446 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Nygaard, B. Langbakk, and B. Romner Age- and Sex-Related Changes of S-100 Protein Concentrations in Cerebrospinal Fluid and Serum in Patients with No Previous History of Neurological Disorder Clin. Chem., March 1, 1997; 43(3): 541 - 543. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
